AWM
AVNS

AE Wealth Management’s Avanos Medical AVNS Stock Holding History

AE Wealth Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,924
Closed -$237K – 2670
2026
Q1 		$237K Buy
16,924
+2,063
+14% +$27.8K ﹤0.01% 1519
2025
Q4 		$167K Buy
14,861
+2,019
+16% +$23.1K ﹤0.01% 1559
2025
Q3 		$148K Buy
+12,842
New +$150K ﹤0.01% 1466

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

AE Wealth Management's AVNS Position: Q2 2026 in Review

AE Wealth Management sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 16,924 shares — an estimated $237K sold.

AE Wealth Management first reported a position in AVNS in Q3 2025 and held it in 3 quarters. The position peaked at $237K in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • AE Wealth Management reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • AE Wealth Management sold 16,924 Avanos Medical shares in Q2 2026, an estimated $237K.
  • AE Wealth Management first reported a position in Avanos Medical in Q3 2025 and held it in 3 quarters.
  • AE Wealth Management's Avanos Medical position peaked at $237K in Q1 2026.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.